Evidence map›Paper›PMID 29344577›Full record

ArticleJournal of the Endocrine Society2017

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.

Grazia Aleppo, Lori M Laffel, Andrew J Ahmann, Irl B Hirsch, Davida F Kruger, Anne Peters, Ruth S Weinstock, Dennis R Harris

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04414579 (The Efficacy and Safety of Faster Insulin Aspart), which is not on this map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04414579 phase4unknown statusnot on this mapstarted 2019, after this paper: background citation

The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus in Patients With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM): a Cross-over Controlled Trial

TypeinterventionalSponsorMountain Diabetes and Endocrine CenterRan2019 to 2021Enrolled45ConditionsType 1 Diabetes MellitusArmsFaster Insulin Aspart (Fiasp®)
3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Continuous Glucose Monitoring: Optimizing Diabetes Care: Executive Summary.Clinical diabetes : a publication of the American Diabetes Association · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Grazia AleppoDivision of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611.
Lori M LaffelPediatric, Adolescent and Young Adult Programs, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215.
Andrew J AhmannDivision of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, Oregon 97239.
Irl B HirschDepartment of Medicine, University of Washington, Seattle, Washington 98195.
Davida F KrugerDivision of Endocrinology, Diabetes and Bone & Mineral, Henry Ford Health System, Detroit, Michigan 48202.
Anne PetersKeck School of Medicine, University of Southern California, Los Angeles, California 90033.
Ruth S WeinstockDepartment of Medicine, SUNY Upstate Medical University, Syracuse, New York 13210.
Dennis R HarrisEndocrine Society, Washington, District of Columbia 20036.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After reviewing previously published methods, we developed a practical approach to adjusting insulin doses based on insulin sensitivity for adult patients with diabetes using rtCGM trend arrow data.

Indexed as

continuous glucose monitoringdiabetesfine-tuninginsulin dose adjustmentinsulin dosingtrend arrows

Identifiers

PMID29344577
PMCPMC5760210

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.